RANI

insider transactions

Rani Therapeutics Holdings, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 3, 26

Kate Mckinley

Chief Business Officer

$0

805.5K sh

Own New
Grant·A
Jun 3, 26

Alireza Javadi

Chief Technical Officer

$0

805.5K sh

Own New
Grant·A
Jun 3, 26

Talat Imran KEY

Chief Executive Officer

$0

3.8M sh

Own New
Grant·A
May 28, 26

Lisa Ann Rometty

Director

$0

123.6K sh

Own New
Grant·A
May 28, 26

Mir A Imran

Director, 10% Owner

$0

123.6K sh

Own New
Grant·A
May 28, 26

Abraham Bassan

Director

$0

123.6K sh

Own New
Grant·A
May 28, 26

Vasudev Jaiprakash Bailey

Director

$0

123.6K sh

Own New
Grant·A
May 28, 26

Jean Luc Butel

Director

$0

123.6K sh

Own New
Grant·A
May 28, 26

Dennis A Ausiello

Director

$0

123.6K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 3, 2026	Kate Mckinley	Chief Business Officer	Grant A	805.5K	New	—	$0
Jun 3, 2026	Alireza Javadi	Chief Technical Officer	Grant A	805.5K	New	—	$0
Jun 3, 2026	Talat Imran KEY	Chief Executive Officer	Grant A	3.8M	New	—	$0
May 28, 2026	Lisa Ann Rometty	Director	Grant A	123.6K	New	—	$0
May 28, 2026	Mir A Imran	Director, 10% Owner	Grant A	123.6K	New	—	$0
May 28, 2026	Abraham Bassan	Director	Grant A	123.6K	New	—	$0
May 28, 2026	Vasudev Jaiprakash Bailey	Director	Grant A	123.6K	New	—	$0
May 28, 2026	Jean Luc Butel	Director	Grant A	123.6K	New	—	$0
May 28, 2026	Dennis A Ausiello	Director	Grant A	123.6K	New	—	$0

About RANI insider trading

This page tracks insider transactions for Rani Therapeutics Holdings, Inc. (RANI) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.